Gerd Zettlmeissl

Chairman at MEDIGENE AG

70 year

Health Technology

Commercial Services

Distribution Services

Profile

Gerd Zettlmeissl is currently Chairman-Supervisory Board at MediGene AG since 2019, Chairman at Valneva SE starting 2026, Chairman-Supervisory Board at MSD Wellcome Trust Hilleman Laboratories Pvt Ltd. since 2013, Director at Aeras Global TB Vaccine Foundation since 2011, and Director at MinervaX ApS.
Former roles include Chairman-Management Board at Intercell AG from 2010 to 2011, Chairman at GlycoVaxyn AG from 2013 to 2015, Chairman at European Medical Solutions from 2017 to 2018, Chairman-Supervisory Board at Themis Bioscience GmbH from 2015 to 2020, Managing Director at Chiron Behring & Co., Director-Supervisory Board at Helmholtz-Zentrum für Infektionsforschung GmbH, and Head-Technical Operations at Chiron Corp.
Education includes a doctorate from the University of Regensburg.

Gerd Zettlmeissl active positions

Companies	Position	Start
MEDIGENE AG	Chairman	2019-05-21
VALNEVA SE	Chairman	2026-06-24
Aeras Global TB Vaccine Foundation Aeras Global TB Vaccine Foundation Miscellaneous Commercial ServicesCommercial Services Aeras Global TB Vaccine Foundation is a non-profit organization, which engages in the development of tuberculosis vaccines in partnership with other biotech, pharmaceutical, and academic organizations. Its product pipeline includes AdS Ag85A, MTBCAV, VPM 1002, and RUTI. The company is headquartered in Rockville, MD.	Director/Board Member	2011-11-13
MSD Wellcome Trust Hilleman Laboratories Pvt Ltd. MSD Wellcome Trust Hilleman Laboratories Pvt Ltd. BiotechnologyHealth Technology Develops and researches vaccines	Chairman	2012-12-31
Minervax ApS Minervax ApS Pharmaceuticals: MajorHealth Technology Develops prophylactic vaccines for pregnant women and older adults	Director/Board Member	-

All active positions of Gerd Zettlmeissl

Former positions of Gerd Zettlmeissl

Companies	Position	End
Themis Bioscience GmbH Themis Bioscience GmbH Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops vaccines to prevent infectious diseases	Chairman	2019-12-31
EUROPEAN MEDICAL SOLUTIONS	Chairman	2018-12-17
GlycoVaxyn AG GlycoVaxyn AG BiotechnologyHealth Technology Developed and produced bioconjugate vaccines	Chairman	2014-12-31
Intercell AG Intercell AG Pharmaceuticals: MajorHealth Technology Manufactures drugs and medicines	Chief Executive Officer	2011-05-09
░░░░░░ ░░░░░	░░░░░ ░░░░░░░░░░░░ ░░░░░░░	-

See the detail of Gerd Zettlmeissl's experience

Training of Gerd Zettlmeissl

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Gerd Zettlmeissl's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	13
Chiron Corp. Chiron Corp. Medical SpecialtiesHealth Technology Provides nucleic acid test for blood screening	Health Technology
Intercell AG Intercell AG Pharmaceuticals: MajorHealth Technology Manufactures drugs and medicines	Health Technology
Aeras Global TB Vaccine Foundation Aeras Global TB Vaccine Foundation Miscellaneous Commercial ServicesCommercial Services Aeras Global TB Vaccine Foundation is a non-profit organization, which engages in the development of tuberculosis vaccines in partnership with other biotech, pharmaceutical, and academic organizations. Its product pipeline includes AdS Ag85A, MTBCAV, VPM 1002, and RUTI. The company is headquartered in Rockville, MD.	Commercial Services
MediGene AG MediGene AG BiotechnologyHealth Technology Engages in the clinical research and development of novel drugs against cancer & autoimmune diseases with focus on personalized immunotherapies	Health Technology
Chiron Behring & Co. Chiron Behring & Co. Medical DistributorsDistribution Services Supplies and developes new vaccine products for adults and children	Distribution Services
University of Regensburg University of Regensburg Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
GlycoVaxyn AG GlycoVaxyn AG BiotechnologyHealth Technology Developed and produced bioconjugate vaccines	Health Technology
European Medical Solutions European Medical Solutions BiotechnologyHealth Technology Develops tools for diagnosis and treatment of immune response-related diseases	Health Technology
Helmholtz-Zentrum für Infektionsforschung GmbH Helmholtz-Zentrum für Infektionsforschung GmbH BiotechnologyHealth Technology Provides infection biology research and development services	Health Technology
Themis Bioscience GmbH Themis Bioscience GmbH Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops vaccines to prevent infectious diseases	Health Technology
Minervax ApS Minervax ApS Pharmaceuticals: MajorHealth Technology Develops prophylactic vaccines for pregnant women and older adults	Health Technology
MSD Wellcome Trust Hilleman Laboratories Pvt Ltd. MSD Wellcome Trust Hilleman Laboratories Pvt Ltd. BiotechnologyHealth Technology Develops and researches vaccines	Health Technology
Valneva SE Valneva SE BiotechnologyHealth Technology Develops and commercializes of prophylactic vaccines for infectious diseases	Health Technology